SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,884,375 | -35.1% | 2,812,500 | 0.0% | 0.70% | -22.4% |
| Q2 2023 | $16,762,500 | +82.3% | 2,812,500 | 0.0% | 0.90% | +76.7% |
| Q1 2023 | $9,196,875 | -17.2% | 2,812,500 | 0.0% | 0.51% | -20.9% |
| Q4 2022 | $11,109,375 | -34.2% | 2,812,500 | 0.0% | 0.64% | -25.2% |
| Q3 2022 | $16,875,000 | -6.7% | 2,812,500 | 0.0% | 0.86% | -12.1% |
| Q2 2022 | $18,084,000 | -22.2% | 2,812,500 | 0.0% | 0.98% | +30.1% |
| Q1 2022 | $23,231,000 | -46.6% | 2,812,500 | 0.0% | 0.75% | -28.3% |
| Q4 2021 | $43,538,000 | -31.3% | 2,812,500 | 0.0% | 1.05% | -30.1% |
| Q3 2021 | $63,338,000 | +14.5% | 2,812,500 | 0.0% | 1.50% | +33.4% |
| Q2 2021 | $55,294,000 | -41.3% | 2,812,500 | 0.0% | 1.13% | -70.3% |
| Q1 2021 | $94,134,000 | – | 2,812,500 | – | 3.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |